Member Info for Sammy95x

Very sensitive to news this share. When big news comes it will take off.

The last time this was this low was September 2020. Rock bottom with a push to the upside on the horizon maybe. This remains a very sensitive stock.

Nobody knows what’s going on behind the scenes. Let them do their stuff I say. I don’t think they should or will be releasing RNS’s each sale from now on. I wouldn’t be surprised if they take a couple of months now to formulate a meaningful update regarding sales/interest for investors.

Just keep loading up on shares when you can afford it, whatever the SP. This will be gobbled up quickly between 2-3 years and the SP will sizzle before hand. Those that try and sell and rebuy for a quick buck might get burnt.

My hope is that Polarean receive a decision today and prepare a RNS for 28/29th. Is that possible? Or will they have to release RNS asap after decision.

4 trading days before the 30th. It’s got to be on any of those days surely. I understand people the panic selling being this close with no news or communication. Holding strong me. Be in it to win it

I agree with all of the above, in my view Polarean has now reached the stage in which it is ready to introduce the product to the healthcare market. The market is there and waiting, this product will sell. There is a decade of evidence to support this, many institutions have wanted this imaging technique and have facilitated the research in discovering its capabilities when applied to a variety of lung conditions. By how much in profit terms is up for debate on this board, the significant investors know this will take 1-2 years after approval to find out (at least). The 2 major setbacks (1st crl and extension) have made new investors weary. All the hype currently is now focused on approval, but that's just the beginning. The reality is that many investors are after the next 'quick buck' and are not prepared wait for this to mature. I've have read the many scholarly articles relating to this technology as I'm sure you all have, the common theme in conclusions is that it's an exciting, high potential, and crucial diagnostic tool for clinicians. The first hurdle is accessing the tough and competitive US market. We only have to wait a tiny bit longer to get a bit of insight on where this will go.

This stagnant SP this close to the big RNS makes me feel that everybody who wants to be invested in this already are. Would be nice to get a bit of a rise soon.
Big fish waiting for a slight nudge of encouragement from sources close to Polarean team? Any thoughts

A magician never reveals his tricks.
If he did would you believe them?

The herd is beginning to move.

Yeah thanks, pretty irrelevant at this point as you say. All the need to know is in the past two years.
It’s going to be a fantastic Christmas… gla

I’m wondering if anyone can help run over the history of Polarean to me to fill in the gaps I am unaware of.
I’ve been very keen on this stock since discovering it 2 years ago, I’ve read a number of the scholarly articles from the universities that currently have their polariser (and there is quite a lot). All promising results as we know. But I came across a podcast on BBC sounds from 2013 talking about the clinical research Oxford has been doing with it. (Talking about the tech as if it were their own.) no mention of Polarean.
When did the company form before going public?
What’s changed since 2013 / 2018 onwards. And does anyone have any in depth knowledge of the research studies, outcomes? Or recommendations of any significant studies ?
I know many respiratory clinicians are begging this tech to be approved.

I suspect most will expect the announcement in the latter halve of the 90 day extended period. Hopefully should see a steady rise throughout November.

I suspect most will expect the announcement in the latter halve of the 90 day extended period. Hopefully should see a steady rise throughout November.

Thanks for this, additional reassurance.

Extremely disappointing. Right, so effectively the new deadline will be the 30th December with that 90 days factored in?
Hard to remain committed to this company with these nit pickers in the FDA last minute finding something to dispute.

Volume of trades has spiked big today. Obviously in the southern direction. Looks like the main attraction will lie in the mid to end of next week.

14 days before Oct 05 last year it jumped 85-110p.
History loves repeating itself like you said so there should be a bump around that date.

There was previous talk/suggestions of further studies of the gas exchange in other regions of the body (brain I remember), could be related to new studies in relation to that? It’s a bit cryptic.

Deadline month tomorrow so the September countdown is on. Probably the final RNS before the big one? Let’s tuck in and see how the SP moves as we pass through Sep. GLA